NBC Securities’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Sell
2,866
-44
-2% -$6.6K 0.03% 568
2026
Q1
$445K Sell
2,910
-1,449
-33% -$222K 0.03% 553
2025
Q4
$601K Buy
4,359
+252
+6% +$33K 0.05% 438
2025
Q3
$527K Sell
4,107
-7,690
-65% -$938K 0.04% 481
2025
Q2
$1.43M Buy
11,797
+179
+2% +$20.2K 0.12% 207
2025
Q1
$1.29M Buy
11,618
+11,608
+116,080% +$1.24M 0.11% 204
2024
Q4
$1.06K Sell
10
-10,652
-100% -$1.14M 0.1% 226
2024
Q3
$1.23M Buy
10,662
+170
+2% +$19.3K 0.1% 207
2024
Q2
$1.12M Buy
10,492
+97
+0.9% +$9.74K 0.1% 215
2024
Q1
$1.11M Buy
10,395
+367
+4% +$37.6K 0.1% 224
2023
Q4
$1.01M Sell
10,028
-48
-0.5% -$4.63K 0.1% 204
2023
Q3
$1.03M Buy
+10,076
New +$1.02M 0.11% 180

Other funds holding NVS

NBC Securities's NVS Position: Q2 2026 in Review

NBC Securities reduced its Novartis (NVS) stake by 1.5% in Q2 2026, selling an estimated $6.6K and leaving 2,866 shares worth $449K. The position accounts for 0.03% of the portfolio, ranked #568.

NBC Securities first reported a position in NVS in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.43M in Q2 2025. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • NBC Securities held 2,866 shares of Novartis worth $449K as of Q2 2026.
  • NBC Securities sold 44 Novartis shares in Q2 2026, an estimated $6.6K.
  • Novartis made up 0.03% of NBC Securities's portfolio in Q2 2026, its #568 holding.
  • NBC Securities first reported a position in Novartis in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Novartis position peaked at $1.43M in Q2 2025.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.